Lista de obras -

A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Novel Drivers of Disease Progression in Primary Sclerosing Cholangitis

artículo científico publicado en 2020

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

artículo científico publicado en 2016

A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis

scientific article published on 01 February 2019

A real-world observational cohort of patients with primary biliary cholangitis: TARGET-primary biliary cholangitis study design and rationale.

artículo científico publicado en 2018

A transcription map of the major histocompatibility complex (MHC) class I region

artículo científico publicado en 1996

Advances in pharmacotherapy for primary biliary cirrhosis

artículo científico publicado en 2014

Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis

artículo científico publicado en 2006

Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis

artículo científico publicado en 2014

B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis.

artículo científico publicado en 2008

Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis

artículo científico publicado en 2010

Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

artículo científico publicado en 2012

Boceprevir for untreated chronic HCV genotype 1 infection

artículo científico publicado en 2011

Bugs in bile: A fly in the ointment?

scientific article published on 03 October 2020

Capsule commentary on Mukhtar et al., Assessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data

artículo científico publicado en 2015

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

artículo científico publicado en 2018

Characterization of three different elements in the 5'-flanking region of the fibronectin gene which mediate a transcriptional response to cAMP ⬇️

artículo científico publicado el 15 de enero de 1991

Cloning and analysis of the promotor region of the human fibronectin gene

artículo científico publicado en 1987

Cloning of a novel MHC-encoded serine peptidase highly expressed by cortical epithelial cells of the thymus

artículo científico publicado en 1999

Costs of hepatitis C

artículo científico publicado en 2001

Cutting Edge Issues in Primary Sclerosing Cholangitis ⬇️

artículo científico publicado el 1 de octubre de 2011

DMT1 gene expression and cadmium absorption in human absorptive enterocytes

artículo científico publicado en 2001

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

artículo científico publicado en 2013

Development and Validation of a Primary Sclerosing Cholangitis-Specific Patient-Reported Outcomes Instrument: The PSC PRO.

artículo científico publicado en 2017

Discussion on the role of hemochromatosis susceptibility gene mutation in protecting against iron deficiency in celiac disease ⬇️

artículo científico publicado el 1 de mayo de 2003

Editorial: biochemical responses do not tell the whole story in primary biliary cholangitis

artículo científico publicado en 2020

Electronic Medical Alerts Increase Screening for Chronic Hepatitis B: A Randomized, Double-Blind, Controlled Trial

artículo científico publicado en 2018

Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis

artículo científico publicado en 2011

Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis

artículo científico publicado en 2011

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

artículo científico publicado en 2016

Human gamma-aminobutyric acid B receptor gene: complementary DNA cloning, expression, chromosomal location, and genomic organization

artículo científico publicado en 1998

Human β-Defensin 2 in Primary Sclerosing Cholangitis

artículo científico publicado en 2017

IL-2 receptor alpha deficiency and features of primary biliary cirrhosis

artículo científico publicado en 2006

Immunological Orchestration of Liver Fibrosis ⬇️

artículo científico publicado el 1 de diciembre de 2012

Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease.

artículo científico publicado en 2010

In situ mass spectrometry of autoimmune liver diseases

artículo científico publicado en 2011

Increasing hepatitis B screening for hmong adults: results from a randomized controlled community-based study.

artículo científico publicado en 2013

Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

artículo científico publicado en 2006

Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis

scientific article published on 17 June 2009

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled tr

artículo científico publicado en 2007

Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis

scientific article published on 05 December 2019

Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection

artículo científico publicado en 2016

Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis

artículo científico publicado en 2014

Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update

artículo científico publicado en 2016

Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations

artículo científico publicado en 2010

Prss16 is not required for T-cell development

artículo científico publicado en 2005

Quality of life and everyday activities in patients with primary biliary cirrhosis

artículo científico publicado en 2007

Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.

artículo científico publicado en 2016

Scratching the surface of cholestatic itch treatments

artículo científico publicado en 2017

The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis ⬇️

artículo científico publicado el 1 de diciembre de 2012

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

artículo científico publicado en 2019

The diagnosis of primary biliary cirrhosis

artículo científico publicado en 2014

The role of iron in T cell development and autoimmunity

artículo científico publicado en 2003

Transforming growth factor beta (TGF-beta) and autoimmunity

artículo científico publicado en 2005

Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary Cholangitis

scientific article published on 10 November 2020

Lista de obras de

A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Novel Drivers of Disease Progression in Primary Sclerosing Cholangitis

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis

A real-world observational cohort of patients with primary biliary cholangitis: TARGET-primary biliary cholangitis study design and rationale.

A transcription map of the major histocompatibility complex (MHC) class I region

Advances in pharmacotherapy for primary biliary cirrhosis

Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis

Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis

B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis.

Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis

Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

Boceprevir for untreated chronic HCV genotype 1 infection

Bugs in bile: A fly in the ointment?

Capsule commentary on Mukhtar et al., Assessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Characterization of three different elements in the 5'-flanking region of the fibronectin gene which mediate a transcriptional response to cAMP ⬇️

Cloning and analysis of the promotor region of the human fibronectin gene

Cloning of a novel MHC-encoded serine peptidase highly expressed by cortical epithelial cells of the thymus

Costs of hepatitis C

Cutting Edge Issues in Primary Sclerosing Cholangitis ⬇️

DMT1 gene expression and cadmium absorption in human absorptive enterocytes

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

Development and Validation of a Primary Sclerosing Cholangitis-Specific Patient-Reported Outcomes Instrument: The PSC PRO.

Discussion on the role of hemochromatosis susceptibility gene mutation in protecting against iron deficiency in celiac disease ⬇️

Editorial: biochemical responses do not tell the whole story in primary biliary cholangitis

Electronic Medical Alerts Increase Screening for Chronic Hepatitis B: A Randomized, Double-Blind, Controlled Trial

Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis

Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

Human gamma-aminobutyric acid B receptor gene: complementary DNA cloning, expression, chromosomal location, and genomic organization

Human β-Defensin 2 in Primary Sclerosing Cholangitis

IL-2 receptor alpha deficiency and features of primary biliary cirrhosis

Immunological Orchestration of Liver Fibrosis ⬇️

Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease.

In situ mass spectrometry of autoimmune liver diseases

Increasing hepatitis B screening for hmong adults: results from a randomized controlled community-based study.

Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled tr

Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis

Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection

Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis

Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update

Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations

Prss16 is not required for T-cell development

Quality of life and everyday activities in patients with primary biliary cirrhosis

Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.

Scratching the surface of cholestatic itch treatments

The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis ⬇️

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

The diagnosis of primary biliary cirrhosis

The role of iron in T cell development and autoimmunity

Transforming growth factor beta (TGF-beta) and autoimmunity

Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary Cholangitis